New Drug Pricing and Market Access [Podcast] PodcastBack Bay Life Science AdvisorsJuly 6, 2021Biotech, Market Access, Drug Pricing, FDA
Back Bay in Cell & Gene: The Next Decade In Gene Therapy Innovation, Six Critical Questions (And Answers) Back Bay in the NewsBack Bay Life Science AdvisorsMay 21, 2021Gene Therapy, Vector Technology, Biotech Investment, Rare Disease, Drug Pricing
STAT: Early Price Setting, Other Market Access Planning is Key for Early-Stage Drug, Device Companies Back Bay in the News, Life Science MediaChristopher Leo, PhD October 29, 2019Drug Pricing, Market Access, Emerging BioPharma, Emerging Companies
